Sharon Chan

Private Equity Investor chez Johnson & Johnson Innovation - JJDC, Inc.

Profil

Sharon is a passionate and respected global health leader with extensive experience in business and product development across pharmaceuticals, medical devices, vaccines and technology platforms.
As VP JLABS Asia Pacific, Sharon is responsible for setting and driving the long-term growth strategy and plan for JLABS in the region, which includes JLABS Singapore and JLABS @ Shanghai.
Supported by a strong commitment to Credo-based leadership, Sharon is a trusted business strategist and collaborator, known for driving innovation strategy with a focus on agility and a caring mindset.
She manages the portfolio of JLABS, collaborates with internal and external business partners across multiple sectors, and drives high-quality company sourcing from innovation hotspots across Asia Pacific.
Sharon brings more than 20 years of diverse, international and life sciences experience from London, Shanghai, Beijing, Hong Kong and Singapore.
She began her career with Sosei-Hepatares and had previously served as a member of the Senior Leadership Team for Baxter responsible for Asia Pacific Business Development.
Prior to joining J&J, Sharon was Head of Asia at Aeras, where she established its Beijing office for the Bill & Melinda Gates Foundation.
In 2020, Sharon was recognized by Forbes China as one of the 50 Top Women in Science & Technology.
In 2021, Sharon was given a Social Impact Leadership Award Honoree by Serica.
Sharon received a Master Degree in Public Health (MPH) at Johns Hopkins Bloomberg School of Public Health, Baltimore, USA; a Master Degree in Business Administration (EMBA) at IE Business School, Madrid, Spain; a Doctorate Degree in Biochemistry and Cardiovascular Medicine (DPhil) at University of Oxford, UK; and a Master Degree in Molecular Biology and Cellular Biochemistry (MBioChem) at University of Oxford, UK.

Postes actifs de Sharon Chan

Sociétés	Poste	Début
Johnson & Johnson Innovation - JJDC, Inc.	Private Equity Investor	01/10/2023